This scenario is not hypothetical. It plays out at research sites every month, across every therapeutic area, in cities and academic medical centers worldwide. And the outcome, more often than not, is under-enrollment. According to published analyses, roughly 80% of clinical trials fail to meet their enrollment timelines, and approximately 30% of investigative sites enroll zero participants. Zero. Not because the patients do not exist, but because no one built a credible plan to find them, reach them, and bring them through the door.

I have spent years watching this pattern repeat, and I can tell you with confidence: the single most reliable predictor of recruitment success is not the therapeutic area, the inclusion criteria, or the visit burden. It is whether someone sat down before the first participant was screened and built a structured, written, multi-channel recruitment plan with defined responsibilities, realistic timelines, and measurable metrics. That is what this lesson teaches you to do.

This scenario is not hypothetical. It plays out at research sites every month, across every therapeutic area, in cities and academic medical centers worldwide. And the outcome, more often than not, is under-enrollment. According to published analyses, roughly 80% of clinical trials fail to meet their enrollment timelines, and approximately 30% of investigative sites enroll zero participants. Zero. Not because the patients do not exist, but because no one built a credible plan to find them, reach them, and bring them through the door.

I have spent years watching this pattern repeat, and I can tell you with confidence: the single most reliable predictor of recruitment success is not the therapeutic area, the inclusion criteria, or the visit burden. It is whether someone sat down before the first participant was screened and built a structured, written, multi-channel recruitment plan with defined responsibilities, realistic timelines, and measurable metrics. That is what this lesson teaches you to do.